Carbohydrate-responsive element binding protein (ChREBP (MLXIPL)) is emerging as an important mediator of glucotoxity both in the liver and in the pancreatic b-cells. Although the regulation of its nuclear translocation and transcriptional activation by glucose has been the subject of intensive research, it is still not fully understood. We have recently uncovered a novel mechanism in the excitable pancreatic b-cell where ChREBP interacts with sorcin, a penta-EF-hand Ca 2C -binding protein, and is sequestered in the cytosol at low glucose concentrations. Upon stimulation with glucose and activation of Ca 2C influx, or application of ATP as an intracellular Ca 2C -mobilising agent, ChREBP rapidly translocates to the nucleus. In sorcin-silenced cells, ChREBP is constitutively present in the nucleus, and both glucose and Ca 2C are ineffective in stimulating further ChREBP nuclear shuttling. Whether an active Ca 2C -sorcin element of ChREBP activation also exists in non-excitable cells is discussed.
Introduction
Obesity and diabetes are currently reaching epidemic proportions across the world (Wild et al. 2004) , and improved understanding at the molecular level of the control of lipid synthesis is eagerly sought. Carbohydrate-responsive element binding protein (ChREBP, official name MLX interacting protein-like, encoded by the MLXIPL gene, also known as MIO, MONDOB, WBSCR14, WS-bHLH and bHLHd14) is a basic helix-loop-helix leucine zipper transcription factor of the MYC/MAX/MAD (MXD1) superfamily (Meng et al. 1998 , de Luis et al. 2000 , Cairo et al. 2001 ) that was first characterised as one of the 17 genes deleted in Williams-Beuren Syndrome (Francke 1999) . It later emerged as the elusive transcription factor responsible for transmitting signal(s) generated in response to extracellular glucose to the L-type pyruvate kinase (L-PK (PKLR)) promoter in hepatocytes (Yamashita et al. 2001 ) and orchestrating the whole lipogenic programme in concert with sterol regulatory element binding protein 1c (SREBP1c) and liver X receptor-a (LXRa NR1H3) (Foretz et al. 1999 , Cha & Repa 2007 , Jeong et al. 2011 . ChREBP binds DNA as a single heterodimer with Max-like protein X (MLX) on canonical CANNTG E-box sequences, frequently not only as a repressor of transcription (Cairo et al. 2001 , Noordeen et al. 2010 ) but also as an activator when two ChREBP/MLX heterodimers interact with each other on the carbohydrate response element (ChoRE, a two E-box motif separated by 5 bp) of glucose-responsive genes (Bergot et al. 1992 , Shih & Towle 1994 , Shih et al. 1995 , Yamashita et al. 2001 , Stoeckman et al. 2004 , Ma et al. 2007 . The molecular basis of this switch is unresolved but may involve the recruitment of different sets of co-repressors or co-activators (Bricambert et al. 2010 , Peterson et al. 2010 .
Acting in the liver, ChREBP is responsible for converting excess carbohydrate to fatty acids for long-term storage (Uyeda & Repa 2006) . Mice deleted for both alleles of Mlxipl display diminished rates of hepatic glycolysis and lipogenesis resulting in high liver glycogen content, low plasma free fatty acid and reduced adipose tissue mass (Iizuka et al. 2004) . Interestingly, a recent genome-wide scan study on man revealed four single nucleotide polymorphisms in the MLXIPL gene associated with raised triglyceride levels (Kooner et al. 2008 ). Wild-type ChREBP may thus permit more efficient food utilisation, fat deposition, and rapid weight gain at times of food abundance (Kooner et al. 2008) . Indeed, loss of ChREBP in leptin-null ob/ob mice protects against obesity and hyperphagia and partially restores glycaemia (Dentin et al. 2006 , Iizuka et al. 2006 .
In addition to its lipogenic role in the liver, ChREBP is a critical regulator of lipogenic genes in the pancreatic b-cell and may play a role in the development of glucolipotoxicity and b-cell failure through lipid accumulation and apoptosis in pancreatic islets of Langerhans in response to high glucose (Wang & Wollheim 2002 , da Silva Xavier et al. 2006 , Cha-Molstad et al. 2009 , Noordeen et al. 2010 , Boergesen et al. 2011 . Table 1 shows a list of significant ChREBP target genes. A better understanding of ChREBP regulation and nuclear translocation in response to elevated glucose concentrations will provide useful information towards the development of pharmacological strategies against rampant diseases like non-alcoholic steatohepatitis and type 2 diabetes (Denechaud et al. 2008) .
Molecular structure
ChREBP is a large protein of 865 amino acids with a M r Z96 500 Da. It contains several functional domains including two nuclear export signal sites located at residues 5-15 and 86-95 (Merla et al. 2004 , Fukasawa et al. 2010 ), a bipartite nuclear localisation signal site located at residues 158-190 (Ge et al. 2011 ), a DNA-binding bHLH/Zip domain and proline-rich regions including multiple phosphorylation sites (Cairo et al. 2001 , Yamashita et al. 2001 . The N-terminal region of ChREBP (amino acids 1-251) interacts directly with a dimeric form of the 14-3-3 protein (Li et al. 2006 , Sakiyama et al. 2008 and is responsible for sub-cellular localisation, while the C-terminal region of ChREBP forms a complex MLX to bind DNA (Cairo et al. 2001 , Stoeckman et al. 2004 .
Regulation of ChREBP activation by glucose
The group of K Uyeda has been at the forefront in identifying ChREBP as the glucose-responsive transcription factor and deciphering its regulation in response to changes in glucose, cAMP and fatty acid availability (Kawaguchi et al. 2001 , Yamashita et al. 2001 . This group's current model proposes that in the liver and primary hepatocytes glucose-dependent nuclear translocation of ChREBP is subject to control through a series of phosphorylation/dephosphorylation reactions. In fasting and low glucose conditions, ChREBP is phosphorylated by protein kinase A (PKA) on S140, S196, S626 and T666 and by AMP-activated protein kinase (AMPK (PRKAA)) on S568, modifications that promote cytosolic retention and inhibit DNA binding. Phosphorylation of ChREBP on S140 and S196 promotes its interaction with 14-3-3 (Sakiyama et al. 2008 , Ge et al. 2011 retaining ChREBP in the cytosol, whereas phosphorylation of residues S568, S626 and T666 inhibits DNA binding. Conversely, high glucose concentrations, by increasing intracellular levels of xylulose 5-phosphate (a metabolite in the pentose phosphate pathway; Kabashima et al. 2003) , favour ChREBP dephosphorylation by protein phosphatase 2A (PP2A). Dissociation of ChREBP from 14-3-3, and binding to importin a, then appears to permit translocation into the nucleus and transcriptional activation (Kawaguchi et al. 2001 , Sakiyama et al. 2008 , Ge et al. 2011 ).
The above model of phosphorylation/dephosphorylationdependent regulation of ChREBP by glucose has, however, et al. (2011) been challenged. First, in primary hepatocytes cultured in vitro, low glucose concentrations are not associated with high cAMP levels in the absence of glucagon, and PKA is not expected to be active under these conditions (Tsatsos & Towle 2006) . Also, in the glucose-responsive pancreatic b-cell line INS1 (832/13), a PP2A-independent pathway has been implicated, as dephosphorylation of Ser-196, Ser-626 and Thr-666 was not sufficient for the nuclear accumulation of ChREBP (Davies et al. 2008) . Moreover, inhibition of PP2A by cantharidic acid did not interfere with ChREBP activation by glucose (Li et al. 2006) . However, caution must be exercised when interpreting data obtained using a pancreatic b-cell line for studies on glucose signalling as these excitable cells represent far from perfect surrogates for hepatocytes. Notably, in the pancreatic b-cell, elevated glucose concentrations are associated with increased intracellular cAMP levels and the activation of PKA signalling (Rabinovitch et al. 1976 , Dyachok et al. 2008 , Tian et al. 2011 as well as PP2A inhibition (Palanivel et al. 2004 , Kowluru 2005 , Parameswara et al. 2005 . Also, suppression of AMPK activity by glucose is well documented in b-cells (da Silva Xavier et al. 2000, Leclerc et al. 2004) , whilst glucose has no effect on AMPK activity in primary hepatocytes (Foretz et al. 1998 ). Furthermore, pentose phosphate pathway activity is very low in pancreatic islets (Hedeskov & Capito 1975 , MacDonald 1993 , and Schuit et al. (1997) , using purified rat b-cells, have demonstrated that acceleration of glucose metabolism acutely suppresses flux through this pathway. All these observations point to the existence of other mechanisms regulating the nuclear translocation of ChREBP in b-cells.
Although previous work in the pancreatic b-cell line INS1 (832/13) identified a glucose-sensing module in the N-terminal region of ChREBP (Li et al. 2006 , Davies et al. 2008 , the exact molecular mechanism(s) through which glucose prompts subcellular relocalisation have remained largely unknown (Postic et al. 2007 ). Whatever the system used, i.e. primary hepatocytes or clonal pancreatic b-cells, the low glucose-driven cytosolic retention domain is located in the N-terminal region of ChREBP because only proteins having the first 251 amino acids are excluded from the nucleus at low glucose concentrations (Sakiyama et al. 2008) .
Our earlier work, using clonal MIN6 pancreatic b-cells, has suggested a role for changes in intracellular free Ca 2C concentrations in the activation of ChREBP by glucose because the use of diazoxide, an opener of ATP-sensitive K C channels that prevents membrane depolarisation and subsequent Ca 2C entry, inhibited ChREBP binding on the L-PK promoter at high glucose (da Silva Xavier et al. 2006) . Indeed, the activation of Ca 2C influx following glucose stimulation is another specific feature of the pancreatic b-cell compared with the hepatocyte (Prentki & Matschinsky 1987 , Sudo & Mariash 1996 . Confirming this previous work, using both MIN6 cells and primary dissociated mouse islet b-cells, we have recently proposed a model in which sorcin, a penta-EF-hand protein that undergoes Ca 2C -dependent conformational changes (Valdivia 1998 , Ilari et al. 2002 , Maki et al. 2002 , Appelblom et al. 2007 ), binds to and sequesters ChREBP in the cytosol at low glucose, through an interaction with the N-terminal glucose-sensing domain of ChREBP (Noordeen et al. 2012) . Following glucose stimulation and Ca 2C influx, sorcin liberates ChREBP, which is then free to translocate to the nucleus. In sorcinsilenced cells, ChREBP is constitutively present in the nucleus, and both glucose and Ca 2C are ineffective in stimulating further ChREBP nuclear shuttling, whereas sorcin overexpression retains ChREBP in the cytosol (Noordeen et al. 2012 ; Fig. 1) .
In extra-pancreatic cells, notably cardiac myocytes, sorcin associates with the ryanodine receptor (RyR; Meyers et al. 1995) , the pore-forming a 1 subunit of voltage-dependent L-type Ca 2C channels (L-type VDCC; Meyers et al. 1998) , and with the sarcoendoplasmic reticulum Ca 2C ATPase (SERCA) pumps (Matsumoto et al. 2005) , to modulate excitation-contraction coupling through changes in intracellular Ca 2C homeostasis (Meyers et al. 2003) . Sorcin inhibits RyR activity (Lokuta et al. 1997 ) and plays a role in terminating the Ca 2C -induced Ca 2C release (CICR; Fabiato 1983 , Farrell et al. 2003 , which would otherwise feed forward and deplete intracellular Ca 2C stores (Stern & Cheng 2004) . Sorcin also exerts a positive role on cardiomyocyte contractility (Frank et al. 2005 , Matsumoto et al. 2005 and in vivo adenoviral transfer of sorcin reverses the contractile abnormalities characteristic of diabetic cardiomyopathy (Suarez et al. 2004 ). Finally, phosphorylation by PKA (Van der Bliek et al. 1986) significantly decreases the ability of sorcin to modulate RyR activity (Lokuta et al. 1997) channels couple membrane excitation to secretion or contraction respectively. Indeed, extracellular glucose stimulates insulin secretion ultimately by increasing intracellular Ca 2C (Henquin 2000) through plasma membrane gated L-type VDCC (Mears 2004) , whereas cAMP-elevating agents like glucagon-like peptide 1 (GLP1 (GCG)) potentiate glucose-simulated insulin secretion (GSIS) by stimulating CICR (Dyachok & Gylfe 2004 , Kang et al. 2005 .
The nature and identity of the metabolite conferring the glucose signal have been the subject of intense research. While it is generally agreed that glucose phosphorylation to glucose 6-phosphate (G6P) by glucokinase (GK) is essential both in the liver (Doiron et al. 1994 , Prip-Buus et al. 1995 , Dentin et al. 2004 ) and in the pancreatic b-cells (Marie et al. 1993 , Wang & Iynedjian 1997 , Li et al. 2010 , some have proposed that, at least in hepatocytes, further metabolism through the non-oxidative branch of the pentose phosphate pathway provided the active signal (Doiron et al. 1996 , Massillon et al. 1998 , Uyeda & Repa 2006 . As mentioned earlier, this was an attractive model as an intermediate of the pentose phosphate pathway, namely xylulose 5-phosphate, had previously been reported to activate PP2A (Nishimura et al. 1994 , Nishimura & Uyeda 1995 , which was already implicated in the transcriptional effect of glucose (Sudo & Mariash 1994 , Foretz et al. 1998 . Alternatively, there are several reports suggesting that G6P itself is a signalling molecule (Foufelle et al. 1992 , Li et al. 2010 , Dentin et al. 2011 ), a major selling point being that 2-deoxyglucose (2-DG), a glucose analogue that is phosphorylated by hexokinases but cannot be further metabolised downstream of GK, is capable of stimulating the expression of ChoRE-containing genes in fat and insulinoma cells (Foufelle et al. 1992 , Marie et al. 1993 , Li et al. 2010 . However, our model of Ca 2C -induced ChREBP release from sorcin provides an alternative explanation as to how 2-DG exerts its effect, i.e. that this may be due to the ATP-lowering effect of 2-DG (Foufelle et al. 1992) . Indeed, lowering of cytosolic ATP/ADP ratios increases cytosolic Ca 2C by inhibiting ATP-dependent pumping into both the extracellular space and intracellular stores (Haworth et al. 1987 , Spivey et al. 1993 , Bright et al. 1995 . The resultant elevation of cytosolic free Ca 2C may then be sufficient to evoke ChREBP nuclear translocation (Noordeen et al. 2012) and thus activate the transcription of target genes. Another argument against the theory promoting G6P as the active metabolite is that G6P levels are elevated during states of hepatic glucose production (Banhegyi et al. 1991) , when glycolysis and lipogenesis are suppressed and ChREBP inactivated (Noriega et al. 2011 ). However, one cannot exclude the possibility that localised intracellular G6P microdomains play a role in signalling. Indeed, G6P next to the mitochondrial outer membrane has been proposed to regulate the nuclear translocation of MONDOA/MLX in rat L6 myocytes (Stoltzman et al. 2008) . However, in our model for the b-cell, the glucose signal is transmitted by intracellular free Ca 2C , and glucose metabolism all the way through glycolysis, Krebs cycle and respiratory chain is necessary to increase intracellular ATP levels sufficiently to close the K-ATP channels and thus stimulate Ca 2C influx through voltage-gated Ca 2C channels, and very likely activation of CICR, although this still remains to be tested specifically.
Role of Ca 2C signalling in glucose regulation of gene expression in non-excitable cells
Whether an active Ca 2C -sorcin element of ChREBP activation exists in non-excitable cells, where Ca 2C signalling is typically initiated by receptor-triggered production of inositol-1,4,5-trisphosphate and the release of Ca 2C from intracellular stores (Berridge et al. 2003) , is not known at the moment. Interestingly, though, an increase in intracellular Ca 2C has been shown to stimulate the expression of fatty acid synthase in adipocytes stimulated with agouti protein ( Jones et al. 1996 ) and a full endoplasmic reticulum (ER) Ca 2C store is necessary for the transmission of the glucose signal in hepatocytes (Sudo & Mariash 1996) . Intriguingly, in primary rat hepatocytes and mhAT3f hepatoma cells, 2-DG was ineffective in inducing L-PK promoter activity (Matsuda et al. 1990 , Lefrancois-Martinez et al. 1994 ). This could be due to the resistance of this cell type to lower intracellular ATP following 2-DG treatment (Koop & Cobbold 1993 , Cheng et al. 2003 ) and therefore to increase cytosolic free Ca 2C . Although the activity of the SPOT14 (S14; THRSP) promoter was not affected by increasing cytosolic Ca 2C with arginine vasopressin in primary rat hepatocytes (Sudo & Mariash 1996) , the presence of a full thapsigargin-sensitive Ca 2C store was necessary for the glucose effect on S14 transcription. Indeed, prior emptying of the ER Ca 2C pool by thapsigargin (Thastrup et al. 1990 , Lytton et al. 1991 inhibited glucose-induced S14 transcription without affecting glucose metabolism (Sudo & Mariash 1996) . Using rat hepatocytes, the same group showed that incubation in low glucose depleted ER Ca 2C stores (Sudo & Mariash 1996) . This latter information could point towards an ER Ca 2C store sensor or to ER stress in relaying the glucose signal to ChREBP (Cunha et al. 2008 , Wang et al. 2009 ). Further work should provide information regarding whether the signalling module reported here may represent a system that allows highly localised changes in cytosolic Ca 2C , perhaps close to the ER or even a specific Ca 2C release channel, to be decoded as a transcriptional response in non-excitable cells.
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